Abcam PLC (ABCM)       14.46  +0.09 (+0.63%)

14.46  +0.09 (+0.63%)

US0003802040 - ADR - After market: 14.46 0 (0%)

Abcam PLC14.46

NASDAQ:ABCM (6/30/2022, 7:00:00 PM)+0.09 (+0.63%)

After market: 14.46 0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 03-14 2022-03-14/dmh Earnings (Next) 07-05 2022-07-05/bmo
Ins Owners N/A Inst Owners 10.51%
Market Cap 3.31B Shares 228.95M
PE 36.15 Fwd PE 41.94
Dividend Yield 0.31% Analysts 76.47
IPO 11-03 2005-11-03

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Growth Stock Screener

Find more growth stocks the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ABCM Daily chart

Company Profile

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. The company is headquartered in Cambridge, Cambridgeshire and currently employs 1,750 full-time employees. The company went IPO on 2005-11-03. The firm is engaged in the identification, development and distribution of biological reagents. The Company’s products are used by various researchers worldwide to study biological pathways critical for scientific research, diagnostics and drug discovery. Its products can be grouped into two categories: research use only (RUO) proteomic tools and antibodies for clinical application. RUO products include protein binding reagents, such as antibodies and immunoassays, and related reagents. Its RUO products are used to detect, quantify, visualize and modify proteins in scientific research experiments, serving as vital tools to enable its customers to develop insights about targets and biological pathways of interest. Antibodies are a core component of many in vitro diagnostic assays and can also be used as therapeutic agents to treat various diseases, including cancer.

Company Info

Abcam PLC

Discovery Drive, Cambridge Biomedical Campus, Hills Road

Cambridge CAMBRIDGESHIRE CB2 0AX

P: 441223696000.0

CEO: Alan Hirzel

Employees: 1750

Website: http://www.abcam.com/

ABCM Twits

Here you can normally see the latest stock twits on ABCM, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example